JP2023082080A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023082080A5 JP2023082080A5 JP2023051686A JP2023051686A JP2023082080A5 JP 2023082080 A5 JP2023082080 A5 JP 2023082080A5 JP 2023051686 A JP2023051686 A JP 2023051686A JP 2023051686 A JP2023051686 A JP 2023051686A JP 2023082080 A5 JP2023082080 A5 JP 2023082080A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- nanoparticles
- vaccine composition
- composition according
- signaling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002105 nanoparticle Substances 0.000 claims 14
- 229960005486 vaccine Drugs 0.000 claims 13
- 206010028980 Neoplasm Diseases 0.000 claims 9
- 201000011510 cancer Diseases 0.000 claims 7
- 230000011664 signaling Effects 0.000 claims 7
- 206010027476 Metastases Diseases 0.000 claims 6
- 208000037819 metastatic cancer Diseases 0.000 claims 6
- 208000011575 metastatic malignant neoplasm Diseases 0.000 claims 6
- 239000002955 immunomodulating agent Substances 0.000 claims 5
- 239000000556 agonist Substances 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 3
- 230000005865 ionizing radiation Effects 0.000 claims 3
- 238000001959 radiotherapy Methods 0.000 claims 3
- 201000003076 Angiosarcoma Diseases 0.000 claims 2
- 102100020715 Fms-related tyrosine kinase 3 ligand protein Human genes 0.000 claims 2
- 101710162577 Fms-related tyrosine kinase 3 ligand protein Proteins 0.000 claims 2
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 2
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 2
- 208000001258 Hemangiosarcoma Diseases 0.000 claims 2
- 101001057748 Human cytomegalovirus (strain AD169) Uncharacterized protein IRL7 Proteins 0.000 claims 2
- 206010029260 Neuroblastoma Diseases 0.000 claims 2
- 229940123384 Toll-like receptor (TLR) agonist Drugs 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 201000007455 central nervous system cancer Diseases 0.000 claims 2
- CJNBYAVZURUTKZ-UHFFFAOYSA-N hafnium(iv) oxide Chemical compound O=[Hf]=O CJNBYAVZURUTKZ-UHFFFAOYSA-N 0.000 claims 2
- 229940127130 immunocytokine Drugs 0.000 claims 2
- 230000002601 intratumoral effect Effects 0.000 claims 2
- 229960002621 pembrolizumab Drugs 0.000 claims 2
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- 239000003970 toll like receptor agonist Substances 0.000 claims 2
- 206010061424 Anal cancer Diseases 0.000 claims 1
- 208000007860 Anus Neoplasms Diseases 0.000 claims 1
- 101100339431 Arabidopsis thaliana HMGB2 gene Proteins 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 102100027207 CD27 antigen Human genes 0.000 claims 1
- 101150013553 CD40 gene Proteins 0.000 claims 1
- 229940045513 CTLA4 antagonist Drugs 0.000 claims 1
- 208000005243 Chondrosarcoma Diseases 0.000 claims 1
- 201000009047 Chordoma Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 208000006168 Ewing Sarcoma Diseases 0.000 claims 1
- 201000008808 Fibrosarcoma Diseases 0.000 claims 1
- 208000032612 Glial tumor Diseases 0.000 claims 1
- 201000010915 Glioblastoma multiforme Diseases 0.000 claims 1
- 206010018338 Glioma Diseases 0.000 claims 1
- 108700010013 HMGB1 Proteins 0.000 claims 1
- 101150021904 HMGB1 gene Proteins 0.000 claims 1
- 102100037907 High mobility group protein B1 Human genes 0.000 claims 1
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims 1
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 claims 1
- 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 claims 1
- 101001057744 Human cytomegalovirus (strain AD169) Uncharacterized protein IRL9 Proteins 0.000 claims 1
- -1 IFNγ Proteins 0.000 claims 1
- 108010047761 Interferon-alpha Proteins 0.000 claims 1
- 102000006992 Interferon-alpha Human genes 0.000 claims 1
- 108010079944 Interferon-alpha2b Proteins 0.000 claims 1
- 102100021592 Interleukin-7 Human genes 0.000 claims 1
- 108010002586 Interleukin-7 Proteins 0.000 claims 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 229940127145 L19-IL2 immunocytokine Drugs 0.000 claims 1
- 208000018142 Leiomyosarcoma Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 208000006644 Malignant Fibrous Histiocytoma Diseases 0.000 claims 1
- 208000000172 Medulloblastoma Diseases 0.000 claims 1
- 206010027406 Mesothelioma Diseases 0.000 claims 1
- 241001467552 Mycobacterium bovis BCG Species 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 208000015634 Rectal Neoplasms Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 206010039491 Sarcoma Diseases 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 208000021712 Soft tissue sarcoma Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 102100024333 Toll-like receptor 2 Human genes 0.000 claims 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 1
- 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 claims 1
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims 1
- 208000015778 Undifferentiated pleomorphic sarcoma Diseases 0.000 claims 1
- 208000008385 Urogenital Neoplasms Diseases 0.000 claims 1
- 208000009956 adenocarcinoma Diseases 0.000 claims 1
- 230000001919 adrenal effect Effects 0.000 claims 1
- 201000005188 adrenal gland cancer Diseases 0.000 claims 1
- 208000024447 adrenal gland neoplasm Diseases 0.000 claims 1
- 201000011165 anus cancer Diseases 0.000 claims 1
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 claims 1
- 206010006007 bone sarcoma Diseases 0.000 claims 1
- 208000011654 childhood malignant neoplasm Diseases 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 210000002808 connective tissue Anatomy 0.000 claims 1
- 229950007409 dacetuzumab Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000003511 endothelial effect Effects 0.000 claims 1
- 210000000981 epithelium Anatomy 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 229950004003 fresolimumab Drugs 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 208000005017 glioblastoma Diseases 0.000 claims 1
- 201000010536 head and neck cancer Diseases 0.000 claims 1
- 208000014829 head and neck neoplasm Diseases 0.000 claims 1
- 229960002751 imiquimod Drugs 0.000 claims 1
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical group C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 claims 1
- 210000002865 immune cell Anatomy 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 201000002313 intestinal cancer Diseases 0.000 claims 1
- 229960005386 ipilimumab Drugs 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 206010024627 liposarcoma Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 229950004563 lucatumumab Drugs 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000012804 lymphangiosarcoma Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000009020 malignant peripheral nerve sheath tumor Diseases 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 206010027191 meningioma Diseases 0.000 claims 1
- 229940035032 monophosphoryl lipid a Drugs 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 208000001611 myxosarcoma Diseases 0.000 claims 1
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 claims 1
- 208000007538 neurilemmoma Diseases 0.000 claims 1
- 208000029974 neurofibrosarcoma Diseases 0.000 claims 1
- 229960003301 nivolumab Drugs 0.000 claims 1
- 201000008968 osteosarcoma Diseases 0.000 claims 1
- 238000011375 palliative radiation therapy Methods 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 229950010773 pidilizumab Drugs 0.000 claims 1
- 206010038038 rectal cancer Diseases 0.000 claims 1
- 201000001275 rectum cancer Diseases 0.000 claims 1
- 201000009571 retroperitoneal cancer Diseases 0.000 claims 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 claims 1
- 206010039667 schwannoma Diseases 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 239000006228 supernatant Substances 0.000 claims 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 230000026683 transduction Effects 0.000 claims 1
- 238000010361 transduction Methods 0.000 claims 1
- 229950007217 tremelimumab Drugs 0.000 claims 1
- 210000004881 tumor cell Anatomy 0.000 claims 1
- 208000037964 urogenital cancer Diseases 0.000 claims 1
- 239000003981 vehicle Substances 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15305810.2 | 2015-05-28 | ||
| EP15305810 | 2015-05-28 | ||
| PCT/EP2016/061989 WO2016189125A1 (en) | 2015-05-28 | 2016-05-27 | Nanoparticles for use as a therapeutic vaccine |
| JP2017561738A JP2018516256A (ja) | 2015-05-28 | 2016-05-27 | 治療用ワクチンとしての使用のためのナノ粒子 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017561738A Division JP2018516256A (ja) | 2015-05-28 | 2016-05-27 | 治療用ワクチンとしての使用のためのナノ粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023082080A JP2023082080A (ja) | 2023-06-13 |
| JP2023082080A5 true JP2023082080A5 (https=) | 2023-10-17 |
| JP7570134B2 JP7570134B2 (ja) | 2024-10-21 |
Family
ID=53298299
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017561738A Pending JP2018516256A (ja) | 2015-05-28 | 2016-05-27 | 治療用ワクチンとしての使用のためのナノ粒子 |
| JP2023051686A Active JP7570134B2 (ja) | 2015-05-28 | 2023-03-28 | 治療用ワクチンとしての使用のためのナノ粒子 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017561738A Pending JP2018516256A (ja) | 2015-05-28 | 2016-05-27 | 治療用ワクチンとしての使用のためのナノ粒子 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11096962B2 (https=) |
| EP (1) | EP3302419B1 (https=) |
| JP (2) | JP2018516256A (https=) |
| KR (1) | KR102727195B1 (https=) |
| CN (2) | CN118286421A (https=) |
| AR (1) | AR104806A1 (https=) |
| AU (2) | AU2016269146B2 (https=) |
| BR (1) | BR112017025553A2 (https=) |
| EA (1) | EA201792560A1 (https=) |
| HK (1) | HK1246160A1 (https=) |
| IL (1) | IL255853B (https=) |
| MA (1) | MA43100A (https=) |
| MX (2) | MX2017015424A (https=) |
| NZ (1) | NZ738527A (https=) |
| TW (2) | TWI910445B (https=) |
| UA (1) | UA124572C2 (https=) |
| WO (1) | WO2016189125A1 (https=) |
| ZA (1) | ZA201708686B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3424533A1 (en) * | 2017-07-05 | 2019-01-09 | Nh Theraguix | Methods for treating tumors |
| CN109010828B (zh) * | 2018-10-12 | 2020-10-20 | 中国科学院高能物理研究所 | 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途 |
| EP3866832B1 (en) | 2018-10-19 | 2024-12-11 | University of Rochester | Immunomodulatory cytokines in combination with radiation treatment for unresectable pancreatic cancer |
| CN116507366A (zh) * | 2020-11-05 | 2023-07-28 | 纳米生物技术公司 | 用于治疗癌症的纳米颗粒组合物 |
| AR131316A1 (es) | 2022-12-12 | 2025-03-05 | Nanobiotix S A | Novedosas nanopartículas de óxido de metal y composiciones de las mismas para uso como radiopotenciadores o para visualizar tejido biológico |
| CN116370625B (zh) * | 2023-03-14 | 2024-10-11 | 浙江大学 | 一种哑铃状的金-氧化铈纳米材料的制备方法及其产品和应用 |
Family Cites Families (111)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4280918A (en) | 1980-03-10 | 1981-07-28 | International Business Machines Corporation | Magnetic particle dispersions |
| US4672040A (en) | 1983-05-12 | 1987-06-09 | Advanced Magnetics, Inc. | Magnetic particles for use in separations |
| US4770183A (en) | 1986-07-03 | 1988-09-13 | Advanced Magnetics Incorporated | Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents |
| US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
| US6099457A (en) | 1990-08-13 | 2000-08-08 | Endotech, Inc. | Endocurietherapy |
| US5370901A (en) | 1991-02-15 | 1994-12-06 | Bracco International B.V. | Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients |
| WO1993026019A1 (en) | 1992-06-08 | 1993-12-23 | Molecular Bioquest, Inc. | Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications |
| EP0654973A4 (en) | 1992-07-21 | 1995-08-09 | Gen Hospital Corp | ARRANGEMENT FOR DELIVERING MEDICINES TO THE LYMPHIC TISSUE. |
| US5395619A (en) | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
| WO1995022963A1 (en) | 1994-02-28 | 1995-08-31 | Medinova Medical Consulting Gmbh | Drug targeting system, method for preparing same and its use |
| GB9509321D0 (en) | 1995-05-09 | 1995-06-28 | Zylepsis Ltd | Methods of and substances for inhibiting oxidative enzymes |
| JPH10120597A (ja) | 1996-10-22 | 1998-05-12 | Eiken Chem Co Ltd | リンパ節高集積性コロイド粒子 |
| DE19716732C2 (de) | 1997-03-07 | 1999-03-25 | Max Delbrueck Centrum | Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung |
| EP0971692B1 (de) | 1997-03-07 | 2003-03-05 | Max-Delbrück-Centrum Für Molekulare Medizin | Spezifische magnetosomen, verfahren zu ihrer herstellung und ihre verwendung |
| DE19726282A1 (de) | 1997-06-20 | 1998-12-24 | Inst Neue Mat Gemein Gmbh | Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern |
| US6161034A (en) | 1999-02-02 | 2000-12-12 | Senorx, Inc. | Methods and chemical preparations for time-limited marking of biopsy sites |
| US6200598B1 (en) | 1998-06-18 | 2001-03-13 | Duke University | Temperature-sensitive liposomal formulation |
| US6726925B1 (en) | 1998-06-18 | 2004-04-27 | Duke University | Temperature-sensitive liposomal formulation |
| US6645464B1 (en) | 1998-07-30 | 2003-11-11 | James F. Hainfeld | Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy |
| WO2001037721A2 (en) | 1999-11-22 | 2001-05-31 | The Research Foundation Of State University Of New York | Magnetic nanoparticles for selective therapy |
| AU3679801A (en) | 2000-02-08 | 2001-08-20 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| ATE320605T1 (de) | 2000-05-05 | 2006-04-15 | Dotierte nanoteilchen als biolabel | |
| WO2002029410A2 (en) | 2000-10-06 | 2002-04-11 | Quantum Dot Corporation | Cells having a spectral signature, and methods of preparation and use thereof |
| MXPA03004298A (es) | 2000-11-20 | 2004-02-12 | Oncolytics Biotech Inc | Metodo para transmitir optimamente virus a masa de tumor solido. |
| US20020127224A1 (en) | 2001-03-02 | 2002-09-12 | James Chen | Use of photoluminescent nanoparticles for photodynamic therapy |
| US6756063B2 (en) | 2001-03-29 | 2004-06-29 | Zoltan Laboratories, Llc | Methods and compositions for the treatment of human and animal cancers |
| DE10154016B4 (de) | 2001-10-26 | 2004-02-12 | Berlin Heart Ag | Magnetflüssigkeit und Verfahren zur ihrer Herstellung |
| WO2003075961A2 (en) | 2002-03-08 | 2003-09-18 | James Hainfeld | Gold nanoparticles used for x-rays imaging |
| US20030191458A1 (en) | 2002-04-03 | 2003-10-09 | Cornelius Diamond | Light-activated drug delivery method and device |
| US7769423B2 (en) | 2002-09-11 | 2010-08-03 | Duke University | MRI imageable liposomes for the evaluation of treatment efficacy, thermal distribution, and demonstration of dose painting |
| US20030125283A1 (en) | 2002-09-16 | 2003-07-03 | Gatenby Robert A. | Therapy of proliferative disorders by direct irradiation of cell nuclei with tritiated nuclear targetting agents |
| AU2004207813B8 (en) | 2003-01-24 | 2010-04-22 | Health Research, Inc. | Use of photodynamic therapy therapeutic agents entrapped in ceramic nanoparticles |
| US7235228B2 (en) | 2003-04-15 | 2007-06-26 | The United States Of America As Represented By The Secretary Of The Navy | Fluorescent-magnetic nanoparticles with core-shell structure |
| US20050084869A1 (en) | 2003-10-20 | 2005-04-21 | Sung Hyun Kim | Novel composition and methods for the diagnosis of lung cancer |
| US20050090732A1 (en) | 2003-10-28 | 2005-04-28 | Triton Biosystems, Inc. | Therapy via targeted delivery of nanoscale particles |
| WO2005046733A1 (en) | 2003-11-17 | 2005-05-26 | Philips Intellectual Property & Standards Gmbh | Contrast agent for medical imaging techniques and usage thereof |
| CA2547024C (en) | 2003-12-22 | 2013-12-17 | Bracco Research Sa | Gas-filled microvesicle assembly for contrast imaging |
| US20080193372A1 (en) | 2004-02-10 | 2008-08-14 | Barnes-Jewish Hospital | Efficacy and Safety of Targeted Particulate Agents with Decoy Systems |
| JP4895151B2 (ja) | 2004-02-27 | 2012-03-14 | 日立金属株式会社 | 鉄系ナノサイズ粒子およびその製造方法 |
| FR2869803B1 (fr) | 2004-05-10 | 2006-07-28 | Nanobiotix Sarl | Particules activables, preparation et utilisations |
| US20050260137A1 (en) | 2004-05-18 | 2005-11-24 | General Electric Company | Contrast agents for magnetic resonance imaging |
| US20070031337A1 (en) | 2004-06-22 | 2007-02-08 | Reinhard Schulte | Nanoparticle enhanced proton computed tomography and proton therapy |
| GB2415374A (en) | 2004-06-25 | 2005-12-28 | Leuven K U Res & Dev | Targeted delivery of biologically active substances using iron oxide/gold core-shell nanoparticles |
| WO2006037081A2 (en) | 2004-09-28 | 2006-04-06 | The Regents Of The University Of California | Nanoparticle radiosensitizers |
| FR2877571B1 (fr) | 2004-11-05 | 2007-04-13 | Nanobiotix Sarl | Nanoparticules pourvues d'un element de ciblage intracellulaire, preparation et utilisations |
| WO2006051732A1 (ja) | 2004-11-10 | 2006-05-18 | Konica Minolta Medical & Graphic, Inc. | 被覆磁性粒子含有製剤およびその製造方法、並びに診断治療システム |
| US20060264804A1 (en) | 2005-04-07 | 2006-11-23 | Yoram Karmon | Device and kit for delivery of encapsulated substances and methods of use thereof |
| FR2884149B1 (fr) | 2005-04-12 | 2007-06-08 | Henri Mehier | Tube implantable destine a l'injection notamment de fluide caloporteur dans tout ou partie d'un tissu humain ou animal |
| US20070092927A1 (en) | 2005-06-13 | 2007-04-26 | University Of Dayton | Photocatalytic particles with directed and controlled redox activity |
| DE102005039579B4 (de) | 2005-08-19 | 2022-06-30 | Magforce Ag | Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen |
| US20090304587A1 (en) | 2005-11-01 | 2009-12-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Biodegradable composite for internal local radiotherapy |
| US20070098640A1 (en) | 2005-11-02 | 2007-05-03 | General Electric Company | Nanoparticle-based imaging agents for X-ray/computed tomography |
| KR100745744B1 (ko) | 2005-11-11 | 2007-08-02 | 삼성전기주식회사 | 나노 입자 코팅 방법 |
| WO2007122956A1 (ja) | 2006-03-24 | 2007-11-01 | Toto Ltd. | 酸化チタン複合体粒子、その分散液、およびそれらの製造方法 |
| JP2009536151A (ja) | 2006-03-30 | 2009-10-08 | 富士フイルム株式会社 | ナノ粒子 |
| EP1852107A1 (en) | 2006-04-19 | 2007-11-07 | Nanobiotix | Magnetic nanoparticles compositions and uses thereof |
| WO2007128066A1 (en) | 2006-05-04 | 2007-11-15 | University Of South Australia | Drug release from nanoparticle-coated capsules |
| US20090191128A1 (en) | 2006-07-10 | 2009-07-30 | Koninklijke Philips Electronics N.V. | Core-shell nanoparticles for thearapy and imaging purposes |
| DE102006041495A1 (de) | 2006-08-29 | 2008-03-20 | Friedrich-Schiller-Universität Jena | Substanzgemisch zur lokalen Deposition von Magnetpartikeln in einem Medium, insbesondere in tumorbefallenem organischem Gewebe, sowie Applikationskit zur Verabreichung |
| NO329127B1 (no) | 2006-09-12 | 2010-08-30 | Epitarget As | Sporbart partikulaert materiale for legemiddelavlevering omfattende et matriseeller membranmateriale, et legemiddel, og et T1- og et T2*- magnetisk resonanskontrastmiddel |
| NO20064315L (no) | 2006-09-22 | 2008-03-24 | Epitarget As | T1 MRI-sporbare medikamentavleveringspartikler and anvendelse derav |
| IL181126A0 (en) | 2006-11-01 | 2007-07-04 | S B Biotechnologies Ltd | Preparation of gold-containing nano-liposome particles and their use in medical therapy |
| EP1920784A1 (en) | 2006-11-13 | 2008-05-14 | Koninklijke Philips Electronics N.V. | Radiation sensitizers in ionizing radiation therapy and imaging |
| US20090004258A1 (en) | 2007-06-27 | 2009-01-01 | National Health Research Institutes | Drug Release from Thermosensitive Liposomes by Applying an Alternative Magnetic Field |
| CA2697042A1 (en) | 2007-08-21 | 2009-02-26 | Alza Corporation | Liposome compositions for in vivo administration of boronic acid compounds |
| JP2009067613A (ja) | 2007-09-11 | 2009-04-02 | Fujifilm Corp | コア−シェル型金属酸化物微粒子及びその製造方法 |
| US20120176016A1 (en) | 2007-09-28 | 2012-07-12 | General Electric Company | Core-shell particulates, articles, and method of making |
| FR2922106B1 (fr) | 2007-10-16 | 2011-07-01 | Univ Claude Bernard Lyon | Utilisation de nanoparticules a base de lanthanides comme agents radiosensibilisants. |
| EP2067485A1 (en) | 2007-12-07 | 2009-06-10 | Koninklijke Philips Electronics N.V. | Drug carrier providing MRI contrast enhancement |
| WO2009081287A2 (en) | 2007-12-21 | 2009-07-02 | University Of Guelph | Polysaccharide nanoparticles |
| DE102008003615A1 (de) | 2008-01-09 | 2009-07-16 | Magforce Nanotechnologies Ag | Magnetische Transducer |
| DE102008008522A1 (de) | 2008-02-11 | 2009-08-13 | Magforce Nanotechnologies Ag | Implantierbare Nanopartikel-enthaltende Produkte |
| US9403789B2 (en) | 2008-02-21 | 2016-08-02 | Sequoia Pharmaceuticals, Inc. | Benzofuran-containing amino acid inhibitors of cytochrome P450 |
| DE102008000852A1 (de) | 2008-03-27 | 2009-10-01 | Bosch Mahle Turbo Systems Gmbh & Co. Kg | Abgasturbolader für ein Kraftfahrzeug |
| WO2009142754A1 (en) | 2008-05-22 | 2009-11-26 | Goverment Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dendritic conjugates and methods of use |
| EP2130553A1 (en) * | 2008-06-05 | 2009-12-09 | Nanobiotix | Inorganic nanoparticles of high density to destroy cells in-vivo |
| WO2010048623A2 (en) | 2008-10-26 | 2010-04-29 | Board Of Regents, The University Of Texas Systems | Medical and imaging nanoclusters |
| US8395131B2 (en) | 2009-06-20 | 2013-03-12 | Xiaodong Wu | Method for three dimensional (3D) lattice radiotherapy |
| EP2275137A1 (en) | 2009-07-10 | 2011-01-19 | Nanobiotix | Metallic nanoparticles, preparation and uses thereof |
| EP2305310A1 (en) | 2009-09-25 | 2011-04-06 | Asociación Centro de Investigación Cooperativa en Biomateriales - CIC biomaGUNE | Gold -coated magnetic glyconanoparticles functionalised with proteins for use as diagnostic and therapeutic agents |
| GB0921596D0 (en) | 2009-12-09 | 2010-01-27 | Isis Innovation | Particles for the treatment of cancer in combination with radiotherapy |
| CA3149284A1 (en) | 2009-12-15 | 2011-07-14 | Incept, Llc | Implants and biodegradable fiducial markers |
| US8580312B2 (en) | 2010-02-17 | 2013-11-12 | National University Corporation Kobe University | Radiation therapy agent |
| NZ602382A (en) | 2010-03-26 | 2014-11-28 | Abraxis Bioscience Llc | Methods of treatment of hepatocellular carcinoma |
| WO2011133228A2 (en) | 2010-04-23 | 2011-10-27 | Pixelligent Technologies, Llc | Synthesis, capping and dispersion of nanocrystals |
| GB201009455D0 (en) | 2010-06-04 | 2010-07-21 | King S College London | Nanoparticles and their uses in molecular imaging |
| US20130177523A1 (en) | 2010-07-13 | 2013-07-11 | University Of Utah Research Foundation | Gold particles and methods of making and using the same in cancer treatment |
| WO2012048289A1 (en) | 2010-10-08 | 2012-04-12 | Board Of Regents, The University Of Texas System | Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications |
| US9782342B2 (en) | 2010-10-11 | 2017-10-10 | Wichita State University | Composite magnetic nanoparticle drug delivery system |
| WO2012104275A2 (en) | 2011-01-31 | 2012-08-09 | Nanobiotix | Nanoparticles delivery systems, preparation and uses thereof |
| EP2670393B8 (en) | 2011-01-31 | 2016-10-05 | Nanobiotix | Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles. |
| JP2014516960A (ja) * | 2011-05-19 | 2014-07-17 | インサーム（インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル） | 抗ヒトｈｅｒ３抗体及びその使用 |
| WO2013059295A2 (en) | 2011-10-17 | 2013-04-25 | Trustees Of Boston University | Polymeric depots for localization of an agent to biological sites |
| EP2782603A1 (en) | 2011-11-25 | 2014-10-01 | Danmarks Tekniske Universitet | Formulation of solid nano-sized particles in a gel-forming system |
| EA029635B1 (ru) | 2011-12-16 | 2018-04-30 | Нанобиотикс | Применение наночастицы, включающей металлический материал, покрытый материалом оксида гафния, в онкологии и композиция, ее содержащая |
| IN2014MN02089A (https=) | 2012-03-20 | 2015-09-11 | Einstein Coll Med | |
| US20150209397A1 (en) | 2012-09-07 | 2015-07-30 | Carnegie Mellon University | Methods and materials for reducing reticuloendothelial system clearance of particles from a subject |
| ITRM20120480A1 (it) | 2012-10-09 | 2014-04-10 | Uni Degli Studi Camerino | Nanoparticelle lipidiche multicomponenti e procedimenti per la loro preparazione. |
| US20140186447A1 (en) | 2012-12-28 | 2014-07-03 | Abraxis Bioscience, Llc | Nanoparticle compositions of albumin and paclitaxel |
| US20140213765A1 (en) | 2013-01-25 | 2014-07-31 | I-Liang Lee | Albumin tissue scaffold |
| AR094577A1 (es) | 2013-01-25 | 2015-08-12 | Nanobiotix | Composiciones para el tratamiento de cáncer, preparación y usos de las mismas |
| WO2014121224A2 (en) | 2013-02-01 | 2014-08-07 | The Trustees Of Dartmouth College | Biodegradable iron oxide nanoparticle gel for tumor bed therapy |
| WO2014191569A1 (en) | 2013-05-30 | 2014-12-04 | Nanobiotix | Pharmaceutical composition, preparation and uses thereof |
| EA201690050A1 (ru) | 2013-06-20 | 2016-05-31 | Нанобиотикс | Композиции и способы для применения в медицинской диагностике |
| US20160136304A1 (en) | 2013-06-20 | 2016-05-19 | Nanobiotix | Compositions and methods for use in oncology |
| EP2886128A1 (en) | 2013-12-20 | 2015-06-24 | Nanobiotix | Pharmaceutical composition comprising nanoparticles, preparation and uses thereof |
| EP3223796B1 (en) | 2014-11-25 | 2021-07-21 | Curadigm Sas | Pharmaceutical compositions, preparation and uses thereof |
| EP3229776B1 (en) | 2014-11-25 | 2023-06-28 | Curadigm Sas | Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof |
| ES2774365T3 (es) | 2014-11-25 | 2020-07-20 | Curadigm Sas | Composición farmacéutica, preparación y usos de la misma |
| SG11201704143YA (en) | 2014-11-25 | 2017-06-29 | Nanobiotix | Pharmaceutical composition, preparation and uses thereof |
| UA123665C2 (uk) | 2014-11-25 | 2021-05-12 | Кюрадігм Сас | Фармацевтична композиція, її одержання і застосування |
-
2016
- 2016-05-27 UA UAA201712689A patent/UA124572C2/uk unknown
- 2016-05-27 US US15/577,482 patent/US11096962B2/en active Active
- 2016-05-27 TW TW112126400A patent/TWI910445B/zh active
- 2016-05-27 CN CN202410296710.7A patent/CN118286421A/zh active Pending
- 2016-05-27 EA EA201792560A patent/EA201792560A1/ru unknown
- 2016-05-27 MA MA043100A patent/MA43100A/fr unknown
- 2016-05-27 HK HK18105609.2A patent/HK1246160A1/zh unknown
- 2016-05-27 MX MX2017015424A patent/MX2017015424A/es unknown
- 2016-05-27 KR KR1020177037576A patent/KR102727195B1/ko active Active
- 2016-05-27 AU AU2016269146A patent/AU2016269146B2/en active Active
- 2016-05-27 BR BR112017025553A patent/BR112017025553A2/pt not_active Application Discontinuation
- 2016-05-27 WO PCT/EP2016/061989 patent/WO2016189125A1/en not_active Ceased
- 2016-05-27 AR ARP160101554A patent/AR104806A1/es unknown
- 2016-05-27 EP EP16727391.1A patent/EP3302419B1/en active Active
- 2016-05-27 TW TW105116729A patent/TWI873079B/zh active
- 2016-05-27 NZ NZ738527A patent/NZ738527A/en unknown
- 2016-05-27 CN CN201680038140.5A patent/CN107708668A/zh active Pending
- 2016-05-27 JP JP2017561738A patent/JP2018516256A/ja active Pending
-
2017
- 2017-11-22 IL IL255853A patent/IL255853B/en active IP Right Grant
- 2017-11-28 MX MX2023007706A patent/MX2023007706A/es unknown
- 2017-12-20 ZA ZA2017/08686A patent/ZA201708686B/en unknown
-
2021
- 2021-04-27 AU AU2021202582A patent/AU2021202582B2/en active Active
- 2021-07-29 US US17/388,066 patent/US20210353670A1/en not_active Abandoned
-
2023
- 2023-03-28 JP JP2023051686A patent/JP7570134B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023082080A5 (https=) | ||
| Reali et al. | IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumor vaccines | |
| Minnar et al. | Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine | |
| US20210353670A1 (en) | Nanoparticles for use as a therapeutic vaccine | |
| JP2012506394A (ja) | 放射線および免疫サイトカインによる癌治療 | |
| Maletzki et al. | Chemo-immunotherapy improves long-term survival in a preclinical model of MMR-D-related cancer | |
| Rafiq et al. | Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects | |
| US20180319861A1 (en) | Combination therapy for malignant diseases | |
| Salewski et al. | Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors | |
| Radosa et al. | Clinical data on immunotherapy in breast cancer | |
| US20230190934A1 (en) | Methods and compositions for treating a tumor | |
| Tubin | A partial tumor irradiation approach for complex bulky disease | |
| Liu et al. | Effect of triple therapy with low-dose total body irradiation and hypo-fractionated radiation plus anti-programmed cell death protein 1 blockade on abscopal antitumor immune responses in breast cancer | |
| CN104906575A (zh) | LSECtin作为黑色素瘤免疫治疗的靶点 | |
| Moorthy et al. | Beyond borders: engineering organ-targeted immunotherapies to overcome site-specific barriers in cancer | |
| Hoesli et al. | Immunotherapy for head and neck squamous cell carcinoma | |
| JP2023549698A (ja) | がんの治療のためのナノ粒子の組成物 | |
| Huang et al. | Development of membrane-bound GM-CSF and IL-18 as an effective tumor vaccine | |
| Hu et al. | 200 NBTXR3 nanoparticle with immunoradiation improves survival and generates long-term anti-tumor memory in an anti-PD1 resistant murine lung cancer model | |
| NZ776598B2 (en) | Nanoparticles for use as a therapeutic vaccine | |
| HK40092801A (zh) | 用於治疗癌症的纳米颗粒组合物 | |
| Meng et al. | 19P Tumor retargeting universal chimeric antigen receptor T cell (TRUE-CAR T) therapy in solid tumors | |
| ANTI | 199 ENHANCED IMMUNE RESPONSES IN HUMAN BREAST AND COLON CANCER FOLLOWING CHECKPOINT THERAPY IN A CD34+ STEM CELL HUMANIZED NCG (HUCD34NCG) MOUSE MODEL | |
| Dhingra | Evolving Paradigms of Personalized Medicine in Oncology | |
| RU2020143065A (ru) | Способы применения модуляторов сплайсинга |